All In Biotech

Drug Trial Radar · NCT04041609

LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)

A Phase II, Randomized, Blinded, Sham Procedure-Controlled, Parallel-Group Trial to Evaluate the Efficacy, Safety and Tolerability of LYR-210 in Adult Subjects With Chronic Sinusitis (LANTERN Study)

Last checked: Nov 19, 2026Latest source record: Jul 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

71

Actual

Start

May 9, 2019

Primary completion

Mar 25, 2020

Study completion Feb 4, 2021

Sponsor

Lead sponsor
Lyra TherapeuticsIndustry
Sponsor type
Industry
First posted
Aug 1, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase II, Randomized, Blinded, Sham Procedure-Controlled, Parallel-Group Trial to Evaluate the Efficacy, Safety and Tolerability of LYR-210 in Adult Subjects with Chronic Sinusitis.

Conditions

  • Chronic Sinusitis
  • Chronic Rhinosinusitis (Diagnosis)

Interventions

  • LYR-210Drug

    A single administration of LYR-210 depot

  • Sham comparatorOther

    Sham comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline (CFBL) in Chronic Sinusitis Symptom Scores at Week 4Time frame: Week 4

Locations

22 sites in 5 countries. Site status is shown where the registry gives one.

  • Royal Brisbane and Woman's Hospital

    Brisbane, Australia

  • Monash Health

    Clayton, Australia

  • The ENT Centre

    Hornsby, Australia

  • Westmead Hospital

    Westmead, Australia

  • University Hospital for Otorhinolaryngology, Medical University of Graz

    Vienna, Austria

  • Fakultni Nemocnice Brno OR

    Brno, Czechia

  • St Anne's Faculty Hospital

    Brno, Czechia

  • Fakultní nemocnice Plzeň

    Pilsen, Czech Republic, Czechia

  • Fakultni Nemocnice Hradec Kralove Klinika otorinolaryngologie a chirurgie hlavy a krku

    Hradec Králové, Prague, Czechia

  • Southern Clinical Trials Waitemata

    Auckland, New Zealand

  • Southern Clinical Trials Ltd

    Christchurch, New Zealand

  • Clinical Trials New Zealand

    Hamilton, New Zealand

  • Middlemore Clinical Trials

    Papatoetoe, New Zealand

  • P3 Research Tauranga

    Tauranga, New Zealand

  • P3 Research Wellington

    Wellington, New Zealand

  • Wellington Hospital

    Wellington, New Zealand

  • Provita Sp. z o.o. Centrum Medyczne Angelius Provita

    Katowice, Poland

  • Centrum Medyczne All-Med

    Krakow, Poland

  • Centrum Medyczne Plejady

    Krakow, Poland

  • Centrum Medyczne PROMED

    Krakow, Poland

  • Centrum Zdrowia MDM

    Warsaw, Poland

  • Vistamed Sp. z o.o.

    Wroclaw, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.